Document:

exv10w10

 

Exhibit 10.10

 

 

8000 Westpark Drive

Suite 500

McLean, VA22102

 

ph 703.748.4005

fax 703.288.6740

 

www.K12.com

March 4, 2005

Mr. John F. Baule

10859 Meadow Pond Lane

Oakton,Va 22124

Dear John:

K12 Inc. (the Company) is pleased to offer you the position of Chief Financial Officer. You (the
Employee) will report directly to Richard Rasmus. This position will be located in our McLean, VA
headquarters.

K12 offers employees an innovative compensation package reflecting our belief in rewarding
performance appropriately. Your salary will be $265,000 on an annualized basis.

In addition, you will become eligible for the following Employment Benefits in accordance with
Company policy:

	•	 	Health, welfare and 401k benefits.
	 
	•	 	Accrual of 20 days of vacation per year pro-rated per Company policy.
	 
	•	 	You will also be eligible to participate in the Company’s bonus plan, pro-rated based
on the date of hire. Your target bonus will be 50% of $265,000, based on Company
performance and the successful completion of performance objectives that will be
determined after your acceptance of this position.
	 
	•	 	Upon acceptance and execution of the appropriate agreements, and subject to Board
of Directors approval, you will be granted 800,000 options to purchase shares of
common stock of K12. Your Stock Option Agreement will incorporate all relevant
provisions of the Stock Option Plan, including vesting schedule and exercise price,
and is made a part hereof.
	 
	•	 	In the event that Employee resigns for “Good Reason” or Company terminates
Employee’s employment with Company for other than “Cause,” death or disability,
the Company shall (a) pay to Employee as severance pay an amount equal to
Employee’s compensation for a period of 365 days from such event, as if Employee
had continued to receive his then current rate of Compensation that existed prior to
the “Good Reason” or termination event; provided that said amount of severance
shall be paid in full during the six month period following the date of termination in
equal installments not less frequently than semi-monthly in accordance with the
Company’s standard payroll practices, and (b) if permitted by the terms of the
Company’s group medical and dental insurance plans, continue to provide Employee
coverage thereunder at no additional cost to Employee for the Severance period or

 

 

March 4, 2005

John F. Baule

Page 2 of 4

 

	 	 	until Employee is eligible for coverage with new employer if earlier, or if not
permitted by the terms of Company’s group medical and dental plans, reimburse Employee
the cost of premiums if he elects to continue the coverage under such plans as
permitted by COBRA for the Severance Period or until Employee is eligible for coverage
with new employer if earlier. Employee shall have the right to continue coverage under
the Company’s group medical and dental plans thereafter at his option and expense to
the extent COBRA may continue to apply. As used herein, the “Severance Period” means
the period commencing on the date of termination of employment and ending three hundred
and sixty five (365) days thereafter. For purposes of this Agreement, a resignation
shall be for “Good Reason” if Employee resigns because Company (or its successor in
interest or acquiror) materially reduces Employees Compensation as of the date of the
event, or assigns Employee a materially different title and responsibilities such that
Employee has been demoted, or relocates the Employee’s place of work more than 50 miles
from the Company’s current headquarters, or Company otherwise materially breaches the
Agreement. The employee shall have thirty (30) days from the date of the event
constituting “Good Reason” to determine whether he will resign for “Good Reason.” For
purposes of the Agreement, a termination shall be for “Cause” if Employee shall (i)
commit an act of fraud, dishonesty, embezzlement or misappropriation involving Company,
(ii) be convicted of, or enter a plea of guilty or no contest to, any crime involving
moral turpitude or dishonesty, (iii) commit an act, or fail to commit an act, involving
Company which amounts to, or with the passage of time would amount to, willful
misconduct, (iv) willfully fail or habitually or grossly neglect to perform job
responsibilities under this Agreement and such failure or neglect is not cured within
fifteen (15) days after written notice to Employee of such failure or neglect, or (v)
engage in any unprofessional conduct which may adversely affect the reputation of the
Company and/or his relationship with its employees, customers, or suppliers.

Your employment with K12 is not for any fixed term. This constitutes “at-will” employment
which either you or the Company may terminate at any time, for any reason, with or without
cause or advance notice. It is further understood that the “at-will” nature of your
employment with K12 is one aspect of employment that cannot be changed except in writing
and signed by the Chief Executive Officer of the Company.

As a K12 employee, you will be expected to abide by all Company rules and regulations. As
a condition of employment, you will be required to read and sign an Employee
Acknowledgement in your orientation on or about your first day of employment. This offer
of employment is contingent upon your submission and completion of 1-9 documentation and a
signed Confidentiality, Proprietary Rights, and Non-Solicitation Agreement. On your first
day, please bring with you two forms of 1-9 acceptable documentation. The enclosed 1-9
information lists examples of acceptable documentation.

This offer is valid until March 4, 2005 and a signed copy of this offer letter, including
a mutually acceptable start date, must be returned to Heather Kane at 8000 Westpark

K12 Inc. 8000 Westpark Drive, Suite 500, McLean, VA 22102

 

 

March 4, 2005

John F. Baule

Page 3 of 4

 

Drive, Suite 500, McLean, VA 22102, by such date. The additional copy should be
retained for your records.

This letter, together with your Confidentiality, Proprietary Rights, and Non-Solicitation
Agreement, provides you with the complete and exclusive statement of your employment
agreement with the Company. The employment terms in this letter supersede any other
written or oral agreements to you concerning employment at K12. If you have any questions
regarding this offer, please contact Heather Kane directly at 703-970-8006.

This Offer Letter together with the Confidentiality, Proprietary Rights, and
Non-Solicitation Agreement and the Stock Option Agreement embodies the entire
representations, warranties, covenants and agreements in relation to the subject matter
hereof. No other representations, warranties, covenants, understandings or agreements in
relation hereto exist between the parties except as otherwise expressly provided herein.
This Agreement is binding upon and inures to the benefit of the parties and their
respective heirs, executors, administrators, personal representatives, successors, and
permitted assigns.

We look forward to establishing a mutually rewarding relationship with you and welcome
your contribution to our company.

Sincerely,

Heather
Kane
Human Resource Manager

K12 Inc.

K12 Inc. 8000 Westpark Drive, Suite 500, McLean, VA 22102

 

 

March 4, 2005

John F. Baule

Page 4 of 4

 

By signing below, you consent that you have read and agree to the terms of the above
offer and agree to start your employment with K12 on Tuesday, March 1, 2005. In addition,
you represent that you are not subject to any agreement, judgement, order, or restriction
which would be violated by your being employed with the Company, or that in any way
restricts your ability to perform services for the Company.

	 	 	 	 	 
	Signature:
	 		 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Print name:
	 	John Baule	 	 
	 
	 	 	 	 
	 
	 	 	 	 
	Date:
	 	3/4/2005	 	 
	 
	 	 	 	 

K12 Inc. 8000 Westpark Drive, Suite 500, McLean, VA 22102

 

 

K12 INC.

FIRST AMENDMENT TO

EMPLOYMENT OFFER LETTER

     WHEREAS, K12 Inc., a Delaware corporation (the “Company”) entered into an employment
offer letter, dated as of March 4, 2005 (the “Letter”) with John F. Baule (the
“Executive”); and

     WHEREAS, the Executive and the Company desire to amend the Letter to recognize subsequent
promotions, salary increases and option grants and to codify and bring current certain changes to
the Executive’s compensation approved by the Board of Directors or its Compensation Committee ( the
“Board”) ;

     NOW, THEREFORE, in consideration of the foregoing, the Executive and the Company hereby agree
that effective as of July 1, 2007 (the “Effective Date”), the Letter be, and it hereby is,
amended as follows (the “Amendment”):

     1. The second paragraph of the Letter is hereby deleted in its entirety and the following is
substituted in lieu thereof:

“K12 offers employees an innovative compensation package reflecting our belief in
rewarding performance appropriately. Accordingly, and in connection with your
promotion to Executive Vice President of Operations and CFO, the Board previously
approved an increase in your initial base salary to $300,000 in 2006 and granted
an option to purchase 400,000 shares of Common Stock of the Company on June 1,
2006. Beginning on July 1, 2007, and in connection with your promotion to Chief
Operating Officer and CFO, your salary will be increased to $340,000 on an
annualized basis, and will be reviewed annually thereafter based on satisfaction
of individual and company performance objectives established by the Board.”

     2. The third bullet point of the third paragraph of the Letter is hereby deleted in its
entirety and the following is substituted in lieu thereof:

“You will also be eligible to participate in the Company’s bonus plan. Your target bonus
will be 70% of your base salary based on the successful completion of individual and
Company performance objectives, with such bonus amount to be determined by the Board of
Directors in its absolute discretion.”

     3. The fourth bullet point of the third paragraph of the Letter is hereby revised and amended
in its entirety and the following is substituted in lieu thereof:

“In addition to option grants previously approved by the Board since your hire date, the
Company will grant to you (subject to certain conditions) (i) stock options to purchase up
to four hundred thousand (400,000) shares of Common

 

 

Stock of the Company at an exercise price of Two Dollars and Sixty-Eight Cents ($2.68) per
share, one-third (1/3) of which shall vest on each of June 30, 2008, June 30, 2009 and June
30, 2010, provided that Executive remains employed by the Company or its affiliates on each
such date, and (ii) stock options to purchase an aggregate of four hundred thousand
(400,000) shares of Common Stock of the Company at an exercise price of Two Dollars and
Sixty-Eight Cents ($2.68) per share, which shall vest upon the satisfaction of certain
performance-based goals for fiscal years 2008, 2009 and 2010 to be determined by the Board
of Directors of the Company in its sole discretion, provided that Executive remains
employed by the Company or its affiliates on the applicable vesting dates. Except as set
forth herein, all such stock options shall be subject to the terms of the Company’s Stock
Option Plan (the “Plan”) and the Company’s form of Stock Option Agreement under the Plan
(the “Stock Option Agreement”). In addition, upon the occurrence of a Vesting Acceleration
Event (as defined in the Stock Option Agreement), all outstanding stock options held by you
immediately prior to the date of such event shall become fully vested and exercisable.”

     4. To the extent not expressly amended hereby, the Letter remains in full force and effect.

     5. The undersigned do hereby consent to the foregoing amendment effective as of July 1, 2007.

	 	 	 	 	 
	 	K12 INC.

 	 
	 	/s/ Andrew Tisch
 	 
	 	Name:  	Andrew Tisch 	 
	 	Title:  	Chairman of the Board 	 
	 
	 
	 	EXECUTIVE

 	 
	 	/s/ John F. Baule
 	 
	 	John F. Baule 	 
	 	 	 
	 

2exv10w13

 

Exhibit 10.13

Loan and Security Agreement

This Loan and Security Agreement No. 4401 (this “Agreement”) is entered into as of
November 22, 2004, by and between Lighthouse Capital Partners V, L.P. (“Lender”) and
Concentric Medical, Inc., a Delaware corporation (“Borrower”) and sets forth the terms and
conditions upon which Lender will lend and Borrower will repay money. In consideration of the
mutual covenants herein contained, the parties agree as follows:

1. Definitions and Construction

1.1 Definitions. Initially capitalized terms used and not otherwise defined herein are defined in
the California Uniform Commercial Code (“UCC”).

“ACH” means the Automated Clearing House electronic funds transfer system.

“Advance” means each amount advanced by Lender to Borrower hereunder, as evidenced by a Note.

“Basic Rate” means a per annum variable rate of interest equal to the highest Prime Rate quoted in
the Wall Street Journal on the Funding Date, plus 1.75%, which rate shall vary concurrently
with any change in the Prime Rate. On and after a particular Advance’s Funding Date, there will be
no further adjustments to the Basic Rate for such Advance.

“Borrower’s Books” means all of Borrower’s books and records, including records concerning
Collateral, Borrower’s assets, liabilities, business operations or financial condition, on any
media, and the equipment containing such information.

“Collateral” means: (i) all property set forth on Exhibit A attached hereto, as such exhibit may
be amended from time to time; (ii) all property of Borrower which comes into Lender’s possession in
which a security interest is perfected by possession while the Obligations are outstanding; and
(iii) all products and proceeds of the foregoing, including proceeds of insurance and proceeds of
proceeds. For purposes of clarification, “Collateral” shall not include “Intellectual Property,”
as such term is defined in Exhibit A or Indebtedness as defined in clause (v) of the definition or
Permitted Indebtedness.

“Commitment” means $6,000,000.

“Commitment Fee” means $10,000.

“Commitment Termination Date” means the earliest to occur of (i) at the election of Lender the
earlier of (a) March 31, 2005 if Borrower has not borrowed at least $1,000,000 by such date; or (b)
September 30, 2005; (ii) any Default or Event of Default, or (iii) in Lender’s reasonable judgment,
any adverse change (for the Borrower) in the management or composition of Borrower’s Board of
Directors after the date hereof.

“Control Agreement” means an agreement substantially in the form of Exhibit I or otherwise
acceptable to Lender.

“Default” means any event that with the passing of time or the giving of notice or both would
become an Event of Default.

“Default Rate” means the lesser of 18% per annum or the highest rate permitted by applicable law.

“Disclosure Schedule” means the schedule attached as Schedule 1 hereto.

“Event of Default” is defined in Section 8.

“Funding Date” means any date on which an Advance is made to or on account of Borrower hereunder.

“Indebtedness” means (i) all indebtedness for borrowed money or the deferred purchase of property
or services, (ii) all obligations evidenced by notes, bonds, debentures or similar instruments,
(iii) all capital lease obligations, and (iv) all contingent obligations, including guaranties and
obligations of reimbursement or respecting letters of credit.

“Lender’s Expenses” means all reasonable costs or expenses (including reasonable attorneys’ fees
and expenses) incurred in connection with the preparation, negotiation, modification,
administration, or enforcement of the Loan or Loan Documents, or the exercise or preservation of
any rights or remedies by Lender, whether or not suit is brought; provided, however, that Lender’s
Expenses for the preparation and negotiation of the Loan Documents shall not exceed the Commitment
Fee. Lender will apply the Commitment Fee received before the date hereof, if any, towards
Lender’s Expenses.

1

 

“Lien” means any lien, security interest, pledge, bailment, lease, mortgage, hypothecation,
conditional sales and title retention agreement, charge, claim, or other encumbrance.

“Liquidation Event” means any of: (i) the sale (in one or a series of related transactions) of all
or substantially all of Borrower’s assets; or (ii) any merger of Borrower or any transaction (or
series of related transactions) to which Borrower is a party and in which in excess of 50% of
Borrower’s voting power is transferred by its existing shareholders, provided that none of the
following shall be considered a Liquidation Event (x) a merger effected exclusively for the purpose
of changing the domicile of the Borrower, (y) an equity financing in which Borrower is the
surviving corporation and in which the stockholders of Borrower immediately prior to such
transaction(s) own 50% or more of the voting power of the surviving corporation following the
transaction(s)or (z) a transaction in which the stockholders of Borrower immediately prior to such
transaction(s) own 50% or more of the voting power of the surviving corporation following the
transaction(s).

“Loan” means all of the Advances, however evidenced, and all other amounts due or to become due
hereunder.

“Loan Documents” means, collectively, this Agreement, the Warrant, the Notes and all other
documents, instruments and agreements entered into between Borrower and Lender in connection with
the Loan, all as amended or extended from time to time.

“Negative Pledge Agreement” means an agreement in the form of Exhibit H.

“Note” means a Secured Promissory Note in the form of Exhibit B.

“Notice of Borrowing” means the form attached as Exhibit D.

“Obligations” means all Loans, debt, principal, interest, fees, charges, Lender’s Expenses and
other amounts, obligations, covenants, and duties owing by Borrower to Lender of any kind or
description (whether pursuant to the Loan Documents or otherwise (with the exception of the
Warrant), and whether or not for the payment of money), whether direct or indirect, absolute or
contingent, due or to become due, now existing or hereafter arising, and including any of the same
obtained by Lender by assignment or otherwise, and all amounts Borrower is required to pay or
reimburse by the Loan Documents, by law, or otherwise.

“Permitted Indebtedness” means: (i) the Loan; (ii) unsecured trade debt incurred in the ordinary
course of Borrower’s business and (iii) Indebtedness secured by clause (ii) of Permitted Liens and
(iv) Indebtedness secured by a Lien described in clause (v) of the defined term “Permitted Liens”
in an amount not to exceed $1,000,000, provided such Indebtedness does not exceed the lesser of the
cost or fair market value of the equipment financed with such Indebtedness and such Indebtedness is
on commercially reasonable terms acceptable to Lender.

“Permitted Liens” means: (i) Liens in favor of Lender; (ii) Liens disclosed in the Disclosure
Schedule; (iii) Liens for taxes, fees, assessments or other governmental charges or levies not
delinquent or being contested in good faith by appropriate proceedings, that do not jeopardize
Lender’s interest in any Collateral; (iv) Liens to secure payment of worker’s compensation,
employment insurance, old age pensions or other social security obligations of Borrower on which
Borrower is current and are in the ordinary course of its business; provided none of the same
diminish or impair Lender’s rights and remedies respecting the Collateral and (v) Liens upon or in
any equipment (including any accessions, attachments, replacements, improvements or proceeds
thereto) acquired or held by Borrower to secure the purchase price of such equipment or
Indebtedness incurred solely for the purposes of financing such equipment;.

“Regulated Substance” means any substance, material or waste the use, generation, handling,
storage, treatment or disposal of which is regulated by any local or state government authority,
including any of the same designated by any authority as hazardous, genetic, cloning, fetal, or
embryonic.

“Responsible Officer” means each of the President and the Vice President of Finance and
Administration of Borrower.

“Term” means the period from and after the date hereof until the full, final and indefeasible
payment and performance of all Obligations.

“Warrant” means the Warrant in favor of Lender and its affiliates to purchase securities of
Borrower substantially in the form of Exhibit C.

1.2 Interpretation. References to “Articles,” “Sections,” “Exhibits,” and “Schedules” are to
articles, sections, exhibits and schedules herein and hereto unless otherwise indicated. “Hereof,”
“herein” and “hereunder” refer to this Agreement as a whole. “Including” is not limiting. All
accounting and financial computations shall be computed in accordance with generally accepted
accounting principles consistently applied (“GAAP”). “Or” is not necessarily exclusive. All
interest computation interest shall be based on a 360-day year and actual days elapsed.

2

 

2. The Loans

2.1 Commitment. Subject to the terms hereof, Lender will make Advances to Borrower up to the
principal amount of the Commitment, before the Commitment Termination Date. Notwithstanding
anything in the Loan Documents to the contrary, Lender’s
obligation to make any Advances or to lend the undisbursed portion of the Commitment shall
terminate on the Commitment Termination Date. Repaid principal of the Advances may not be
re-borrowed.

2.2 The Advances. A Note setting forth the specific terms of repayment will evidence each Advance.
No Advance will be made for less than $500,000, unless less than $500,000 remains available under
the Commitment for borrowing. Absence of a Note evidencing any portion of the Loan shall not
impair Borrower’s obligation to repay it to Lender.

2.3 Terms of Payment, Repayment.

     (a) Repayment. Borrower shall repay the principal and pay interest on each Advance on the
terms set forth in the applicable Note. Amounts not paid when due hereunder or under the Note
shall bear interest at the Default Rate. If a court of competent jurisdiction determines that
Lender has received payments that, if interest, would exceed the maximum lawfully permitted, Lender
will instead apply such money to fees and expenses and then to early prepayment of principal with
all applicable pre-payment penalties.

     (b) ACH. All payments due to Lender must be, at Lender’s option, paid to Lender in cash or
through ACH. Borrower shall execute and deliver the ACH Authorization Form substantially in the
form of Exhibit G. If the ACH payment arrangement is terminated for any reason, Borrower shall
make all payments due to Lender at Lender’s address specified in Section 11.

     (c) Default Rate. While an Event of Default has occurred and is continuing, interest on the
principal amount of the Loan shall be increased to the Default Rate. Lender’s failure to charge or
accrue interest at the Default Rate during the existence of a Default shall not be deemed a waiver
by Lender of its right or claim thereto.

     (d) Date. Whenever any payment due under the Loan Documents is due on a day other than a
business day, such payment shall be made on the next succeeding business day, and such extension of
time shall be included in the computation of interest or fees, as the case may be.

2.4 Fees. Borrower shall pay to Lender the following:

     (a) Commitment Fee. The Commitment Fee, which has been previously paid by Borrower, and shall
be applied by Lender to Lender’s Expenses and other Obligations;

     (b) Late Fee. On demand, a late charge on any sums due hereunder that are not paid when due,
in an amount equal to 2% of the past due amount, payable on demand.

     (c) Lender’s Expenses. The payment of all Lender’s Expenses, which may become due to Lender
by Borrower hereunder shall be payable by Borrower promptly on written demand (with reasonable
detail of such expenses) by Lender. All Lender’s Expenses not paid when due shall bear interest as
principal at the then-applicable rate of interest.

3. Conditions of Advances; Procedure for requesting Advances

3.1 Conditions Precedent to any and all Advances. The obligation of Lender to make any Advances is
subject to each and every of the following conditions precedent in form and substance satisfactory
to Lender in its sole discretion: (i) this Agreement, a Note evidencing the Advance, the Warrant,
and all other UCC financing statements, and other documents required or as specified herein have
been duly authorized, executed and delivered; (ii) no Default or Event of Default has occurred and
is continuing; (iii) delivery of a Notice of Borrowing with respect to the proposed Advance; (iv)
Lender’s security interests in the Collateral are valid and first priority, except for Permitted
Liens; and (v) all such other items as Lender may reasonably deem necessary or appropriate have
been delivered or satisfied. The extension of an Advance prior to the receipt by Lender of any of
the foregoing shall not constitute a waiver by Lender of Borrower’s obligation to deliver such
item.

3.2 Procedure for Making Advances. For any Advance, Borrower shall provide Lender an irrevocable
Notice of Borrowing at least 7 business days prior to the desired Funding Date. Borrower shall
execute and deliver to Lender a Note and such other documents and instruments as Lender may
reasonably require for each Advance made. Borrower authorizes Lender to disburse Advances as
directed in any Notice of Borrowing executed solely by a Responsible Officer of Borrower.

3

 

4. Creation of Security Interest

4.1 Grant of Security Interest. Borrower grants to Lender a valid, first priority, continuing
security interest in all present and future Collateral in order to secure prompt, full, faithful
and timely payment and performance of all Obligations.

4.2 Inspections. During the Term, Lender shall have the right upon reasonable prior notice and
with minimal practical interference to Borrower’s business, to inspect Borrower’s Books, including
computer files, and to make copies, and to test, inspect and appraise the Collateral, in order to
verify any matter relating to Borrower or the Collateral.

4.3 Authorization to File Financing Statements. Borrower irrevocably authorizes Lender at any time
and from time to time to file in any jurisdiction any financing statements and amendments that: (i)
name Collateral as collateral thereunder, regardless of whether any particular Collateral falls
within the scope of the UCC; (ii) contain any other information required by the UCC for sufficiency
or filing office acceptance, including organization identification numbers; and (iii) contain such
language as Lender determines helpful in acquiring or preserving rights against third parties.
Borrower ratifies any such filings made prior to the date hereof.

5. Representations and Warranties

Borrower represents, warrants and covenants as follows:

5.1 Due Organization and Qualification. Borrower is a corporation duly formed, existing and in
good standing under the laws of its state of incorporation and qualified and licensed to do
business in, and is in good standing in, any state in which the conduct of its business or its
ownership of property requires that it be so qualified or in which the Collateral is located,
except where the failure to do so would not have an adverse effect on Borrower.

5.2 Authority. Borrower has all corporate power and authority, and has taken all actions, and has
obtained all third party consents necessary to execute, deliver, and perform the Loan Documents.

5.3 Disclosure Schedule. All information on the Disclosure Schedule is true, correct and complete.

5.4 Authorization; Enforceability. The execution and delivery hereof, the granting of the security
interest in the Collateral, the incurring of the Obligations, the execution and delivery of all
Loan Documents and the consummation of the transactions herein and therein contemplated have been
duly authorized by all necessary action by Borrower. The Loan Documents constitute legal, valid
and binding obligations of Borrower, enforceable in accordance with their terms, except as
enforceability may be limited by bankruptcy or similar laws relating to enforcement of creditors’
rights generally.

5.5 Name and Location. Borrower has previously done business under the name of Neomed Inc. before
changing the name to that specified on the signature page hereof during Borrower’s Series A
Preferred Stock financing. The chief executive office, principal place of business, and the place
where Borrower maintains its records concerning the Collateral is set forth in Section 11. The
Collateral is presently located at the address(es) set forth in Section 11 and on the Disclosure
Schedule.

5.6 Litigation. All actions or proceedings pending by or against Borrower before any court or
administrative agency are set forth on the Disclosure Schedule.

5.7 Financial Statements. All financial statements and statements respecting Collateral that have
been or may hereafter be delivered by Borrower to Lender are true, complete and correct in all
material respects for the periods indicated.

5.8 Solvency. Borrower is able to pay its debts (including trade debts) as they come due.

5.9 Taxes. Borrower has filed and will file all required tax returns in accordance with applicable
law, and has paid and will pay all taxes it owes in accordance with applicable law.

5.10 Rights; Title to Assets. Borrower possesses and owns all necessary assets, rights,
trademarks, trade names, copyrights, patents, patent rights, franchises and licenses which it needs
to conduct of its business as now operated or proposed to be operated. Borrower has good title to
its assets, free and clear of any Liens, except for Permitted Liens.

4

 

5.11 Full Disclosure. No written representation, warranty or other statement made by Borrower in
any Loan Document, certificate or statement furnished to Lender contains any untrue statement of a
material fact or omits to state a material fact necessary in order to make the statements contained
in such certificates or statements not misleading.

5.12 Regulated Substances. To its knowledge, Borrower complies and will comply with all laws
respecting Regulated Substances.

5.13 Automatic Reaffirmation. Each Notice of Borrowing will constitute (i) a representation that
there does not exist any Default and (ii) a reaffirmation as of the date thereof of all of the
representations and warranties contained in Section 5, provide that Borrower may deliver a
supplement to the Disclosure Schedule to disclose any fact or circumstance arising after the date
hereof.

6. Affirmative Covenants

Borrower covenants and agrees that it shall do all of the following:

6.1 Good Standing and Compliance. Borrower shall maintain all governmental licenses, rights and
agreements necessary for its operations or business and comply in all material respects with all
statutes, laws, ordinances and government rules and regulations to which it is subject.

6.2 Financial Statements, Reports, Certificates. Borrower shall deliver to Lender: (i) as soon as
prepared, and no later than 30 days after the end of each calendar month, a balance sheet, income
statement and cash flow statement covering Borrower’s operations during such period; (ii) as soon
as prepared, but no later than 90 days after the end of the fiscal year, or such other time period
as approved by the Borrower’s board of directors, audited financial statements prepared in
accordance with GAAP, together with an opinion that such financial statements fairly present
Borrower’s financial condition by an independent public accounting firm reasonably acceptable to
Lender; (iii) promptly upon notice thereof, a report of any legal or administrative action pending
or threatened against Borrower which is likely to result in liability to Borrower in excess of
$50,000; and (iv) such other financial information as Lender may reasonably request from time to
time. Financial statements delivered pursuant to subsections (i) and (ii) above shall be
accompanied by a certificate signed by a Responsible Officer (each an “Officer’s Certificate”) in
the form of Exhibit F.

6.3 Notice of Defaults. Reasonably promptly after discovering any Default or Event of Default, an
Officer’s Certificate setting forth the facts relating to or giving rise thereto, and the
Borrower’s proposed action with respect thereto.

6.4 Use; Maintenance. Borrower, at its expense, shall (i) maintain the Collateral in good
condition, reasonable wear and tear excepted, and will comply in all material respects with all
laws, rules and regulations regarding use and operation of the Collateral and (ii) repair or
replace any lost or damaged Collateral, other than Collateral that is obsolete or worthless at the
time of loss or damage and other than Collateral that Borrower determines in good faith is not
necessary or useful in the conduct of its business.

6.5 Insurance. Borrower, at its own expense, shall maintain insurance in amounts and coverages
reasonably satisfactory to Lender. Each insurance shall: (i) name Lender as loss payee or
additional insured, as appropriate, (ii) provide for insurer’s waiver of its right of subrogation
against Lender and Borrower, (iii) provide that such insurance shall not be invalidated by any
action of, or breach of warranty by, Borrower and waive set-off, counterclaim or offset against
Lender, (iv) be primary without a right of contribution of Lender’s insurance, if any, or any
obligation on the part of Lender to pay premiums of Borrower, and (v) require the insurer to give
Lender at least 30 days prior written notice of cancellation. Borrower shall furnish all
certificates of insurance required by Lender.

6.6 Loss Proceeds. So long as no Default has occurred, any proceeds of insurance on or condemnation
of Collateral shall, at Borrower’s election and so long as Lender’s security interest in such
proceeds remains first priority, be used either to repair or replace such Collateral, other than
Collateral that Borrower determines in good faith is not necessary or useful in the conduct of its
business.

6.7 Further Assurances. At any time and from time to time, Borrower shall execute and deliver such
further instruments and take such further action as Lender may reasonably request to effect the
intent and purposes hereof, to perfect and continue perfected and of first priority Lender’s
security interests in the Collateral, and to effect and maintain ACH payment arrangements.

6.8 Account Control Agreements. Borrower shall maintain in full force and effect, and comply with,
all Control Agreements now or from time to time entered into by and among Lender, Borrower, and
depository or other institutions with whom Borrower maintains cash, securities, or other monetary
or security entitlements. With respect to any Control Agreement that require the advance consent
of Lender to Borrower’s withdrawal of funds prior to or irrespective of Lender’s delivery of a
notice of exclusive control or other foreclosure, although Lender shall undertake good faith
efforts to respond expeditiously to provide the requested permission, Borrower agrees to provide or
cause Lender to be provided at least 5 business days advance written notice from the institution
for such permissions.

5

 

7. Negative Covenants

Borrower will not do any of the following:

7.1 Location of Collateral. Without giving 30 days prior written notice to Lender, change its
chief executive office or principal place of business or remove, except in the ordinary course of
Borrower’s business, the Collateral or Borrower’s Books from the premises listed in Section 11.

7.2 Extraordinary Transactions. Enter into any transaction not in the ordinary course of
Borrower’s business, including the sale, lease, license or other disposition of its assets, other
than sales of inventory in the ordinary course of Borrower’s business.

7.3 Restructure. Make any material change in Borrower’s financial structure or substantially
curtail its medical devices business operations (other than through the sale of preferred stock to
equity investors which does not result in a change of control of Borrower); cause a Liquidation
Event; or suspend operation of Borrower’s business.

7.4 Liens. Create, incur, assume or suffer to exist any Lien of any kind with respect to any of
its property, whether now owned or hereafter acquired, except for Permitted Liens.

7.5 Indebtedness. Create, incur, assume or suffer to exist any Indebtedness, other than Permitted
Indebtedness.

7.6 Distributions. Pay any dividends or distributions, or redeem or purchase, any capital stock,
except for repurchases of capital stock from departing employees, consultants or directors, under
repurchase agreements approved by the Borrower’s Board of Directors

7.7 Transactions with Affiliates. Directly or indirectly enter into any transaction with any
affiliate which is on terms less favorable to Borrower than would be obtained in an arm’s length
transaction with a non-affiliated entity; provided, any such transaction shall not be a breach of
this Section 7.7 if approved by a disinterested majority of the Borrower’s Board of Directors.

7.8 Compliance. Become an “investment company” under the Investment Company Act of 1940 or extend
credit to purchase or carry margin stock; fail to meet the minimum funding requirements of ERISA;
permit a Reportable Event or Prohibited Transaction, as defined in ERISA, to occur; fail to comply
with the Federal Fair Labor Standards Act or violate any other law or regulation, or permit any of
its subsidiaries to do so, unless such failure or violation shall not result in an adverse effect
on the business of Borrower.

7.9 UCC Effectiveness. Without giving Lender 30 days advance written notice, change its name,
jurisdiction of organization, or take any other action that could render Lender’s financing
statements misleading.

7.10 Deposit and Securities Accounts. Maintain any deposit accounts or accounts holding securities
owned by Borrower except accounts in which Lender has obtained a perfected first priority security
interest.

8. Events of Default

Any one or more of the following shall constitute an Event of Default by Borrower hereunder:

8.1 Payment. Borrower fails to pay when due and payable in accordance with the Loan Documents any
portion of the Obligations, or cancels an ACH payment or transfer Lender has initiated in
conformity with the terms hereof.

8.2 Certain Covenant Defaults. Borrower fails to perform any obligation under Section 6.5 or 6.6,
or violates any of the covenants contained in Section 7.

8.3 Other Covenant Defaults. Borrower fails or neglects to perform, keep, or observe any other
term, provision, condition, covenant, or agreement contained in this Agreement, in any of the other
Loan Documents, or in any other present or future agreement between Borrower and Lender and has
failed to cure such failure within 15 days after its occurrence.

8.4 Attachment. Any material portion of Borrower’s assets is attached, seized, subjected to a
government levy, lien, writ or distress warrant, or comes into the possession of any trustee or
receiver and the same is not returned, removed, waived, stayed, discharged or rescinded within 10
days.

6

 

8.5 Other Agreements. There is a default in any agreement to which Borrower is a party resulting
in a right by a third party, whether or not exercised, to accelerate the maturity of any
Indebtedness, greater than $100,000.

8.6 Judgments. One or more judgments for an aggregate of at least $50,000 is rendered against
Borrower and remains unsatisfied and unstayed for more than 30 days.

8.7 Injunction. Borrower is enjoined, restrained, or in any way prevented by court order from
continuing to conduct any material part of its business affairs, or if a judgment or other claim
becomes a Lien upon any material portion of Borrower’s assets, and, in the case of an injunction,
such injunction is not dismissed or stayed within 20 days.

8.8 Misrepresentation. Any representation, statement, or report made to Lender by Borrower or any
Responsible Officer or authorized officer, employee, agent, or director of Borrower purporting to
speak on behalf of Borrower was false or misleading when made.

8.9 Enforceability. Lender’s ability to enforce its rights against Borrower or any Collateral is
impaired in any material respect, or Borrower asserts that any Loan Document is not a legal, valid
and binding obligation of Borrower enforceable in accordance with its terms.

8.10 Involuntary Bankruptcy. An involuntary bankruptcy case remains undismissed or unstayed for 30
days or, if earlier, an order granting the relief sought is entered.

8.11 Voluntary Bankruptcy or Insolvency. Borrower commences a voluntary case under applicable
bankruptcy or insolvency law, consents to the entry of an order for relief in an involuntary case
under any such law, or consents or is subject to the appointment of or taking possession by a
receiver, liquidator, assignee, trustee, custodian or other similar official of Borrower or any
substantial part of its property, or makes an assignment for the benefit of creditors, or fails
generally or admits in writing to its inability to pay its debts as they become due, or takes any
corporate action in furtherance of any of the foregoing.

8.12 Merger without Assumption. Borrower is acquired by or merges into any other business entity,
and such acquirer or resulting entity either: (i) does not provide an unconditional, unlimited
guaranty of the Obligations in form and substance satisfactory to Lender or (ii) is of a credit
quality unacceptable to Lender.

9. Lender’s Rights and Remedies

9.1 Rights and Remedies. Upon the occurrence and continuance of any Event of Default, Lender may,
at its election, without notice of election and without demand, do any one or more of the
following, all of which are authorized by Borrower: (i) accelerate and declare the Loan and all
Obligations immediately due and payable; (ii) make such payments and do such acts as Lender
considers necessary or reasonable to protect its security interest in the Collateral, with such
amounts becoming Obligations bearing interest at the Default Rate; (iii) exercise any and all other
rights and remedies available under the UCC or otherwise; (iv) require Borrower to assemble the
Collateral at such places as Lender may reasonably designate; (v) enter premises where any
Collateral is located, take, maintain possession of, or render unusable the Collateral or any part
of it; (vi) without notice to Borrower, set off and recoup against any portion of the Obligations;
(vii) ship, reclaim, recover, store, finish, maintain, repair, prepare for sale, advertise for
sale, and sell the Collateral, in connection with which Borrower hereby grants Lender a license to
use without charge Borrower’s premises, labels, name, trademarks, and other property necessary to
complete, advertise, and sell any Collateral; and (viii) sell the Collateral at one or more public
or private sales.

9.2 Power of Attorney in Respect of the Collateral. Borrower hereby irrevocably appoints Lender
(which appointment is coupled with an interest) its true and lawful attorney in fact with full
power of substitution, for it and in its name to, upon an Event of Default: (i) ask, demand,
collect, receive, sue for, compound and give acquittance for any and all Collateral with full power
to settle, adjust or compromise any claim, (ii) receive payment of and endorse the name of Borrower
on any items of Collateral, (iii) make all demands, consents and waivers, or take any other action
with respect to, the Collateral, (iv) file any claim or take any other action, in Lender’s or
Borrower’s name, which Lender may reasonably deem appropriate to protect its rights in the
Collateral, or (v) otherwise act with respect to the Collateral as though Lender were its outright
owner.

9.3 Charges. If Borrower fails to pay any amounts required hereunder to be paid by Borrower to any
third party, Lender may at its option pay any part thereof and any amounts so paid including
Lender’s Expenses incurred shall become Obligations, immediately due and payable, bearing interest
at the Default Rate, and secured by the Collateral. Any such payments by Lender shall not
constitute an agreement to make similar payments or a waiver of any Event of Default.

7

 

9.4 Remedies Cumulative. Lender’s rights and remedies under the Loan Documents and all other
agreements with Borrower shall be cumulative. Lender shall have all other rights and remedies as
provided under the UCC, by law, or in equity. No exercise by Lender of one right or remedy shall
be deemed an election, and no waiver by Lender of any Event of Default shall be deemed a continuing
waiver. No delay by Lender shall constitute a waiver, election, or acquiescence.

9.5 Application of Collateral Proceeds. Lender will apply proceeds of sale, to the extent actually
received in cash, in the manner and order it determines in its sole discretion, and as prescribed
by applicable law.

10. Waivers; Indemnification

10.1 Waivers. Without limiting the generality of the other waivers made by Borrower herein, to the
maximum extent permitted under applicable law, Borrower hereby irrevocably waives all of the
following: (i) any right to assert against Lender as a defense, counterclaim, set-off or
crossclaim, any defense (legal or equitable), set-off, counterclaim, crossclaim and/or other claim
(a) which Borrower may now or at any time hereafter have against any party liable to Lender in any
way or manner, or (b) arising directly or indirectly from the present or future lack of perfection,
sufficiency, validity and/or enforceability of any Loan Document, or any security interest; (ii)
presentment, demand and notice of presentment, dishonor, notice of intent to accelerate, protest,
default, nonpayment, maturity, release, compromise, settlement, extension or renewal of any or all
accounts, documents, instruments, chattel paper and guaranties at any time held by Lender on which
Borrower may in any way be liable and hereby ratifies and confirms whatever Lender may do in this
regard; (iii) the benefit of all marshalling, valuation, appraisal and exemption laws; (iv) the
right, if any, to require Lender to (a) proceed against any person liable for any of the
Obligations as a condition to or before proceeding hereunder; or (b) foreclose upon, sell or
otherwise realize upon or collect or apply any other property, real or personal, securing any of
the Obligations, as a condition to, or before proceeding hereunder; (v) any
demand for possession before the commencement of any suit or action to recover possession of
Collateral; and (vi) any requirement that Lender retain possession and not dispose of Collateral
until after trial or final judgment.

10.2 Lender’s Liability for Collateral. Subject to the applicable provisions of the UCC, Lender
shall not in any way or manner be liable or responsible for: (i) the safekeeping of any
Collateral; (ii) any loss or damage thereto occurring or arising in any manner or fashion from any
cause; (iii) any diminution in the value thereof; or (iv) any act or default of any carrier,
warehouseman, bailee, forwarding agency, or other person or entity whomsoever. All risk of loss,
damage or destruction of the Collateral shall be borne by Borrower. Lender will have no
responsibility for taking any steps to preserve rights against any parties respecting any
Collateral. Lender’s powers hereunder are conferred solely to protect its interest in the
Collateral and do not impose any duty to exercise any such powers. None of Lender or any of its
officers, directors, employees, agents or counsel will be liable for any action lawfully taken or
omitted to be taken hereunder or in connection herewith (excepting gross negligence or willful
misconduct), nor under any circumstances have any liability to Borrower for lost profits or other
special, indirect, punitive, or consequential damages. Lender retains any documents delivered by
Borrower only for its purposes and for such period as Lender, at its sole discretion, may determine
necessary, after which time Lender may destroy such records without notice to or consent from
Borrower.

10.3 Indemnification. Borrower shall defend, indemnify, and hold Lender and each of its officers,
directors, employees, counsel, partners, agents and attorneys-in-fact (each, an “Indemnified
Person”) harmless from and against any and all liabilities, obligations, losses, damages,
penalties, actions, judgments, suits, costs, charges, expenses or disbursements (including Lender’s
Expenses and reasonable attorney’s fees and the allocated reasonable cost of in-house counsel) of
any kind or nature whatsoever with respect to the execution, delivery, enforcement, performance and
administration of this Agreement and any other Loan Documents, or the transactions contemplated
hereby and thereby, with respect to noncompliance with laws or regulations respecting Regulated
Substances, government secrecy or technology export, or any Lien not created by Lender or right of
another against any Collateral, even if the Collateral is foreclosed upon or sold pursuant hereto,
and with respect to any investigation, litigation or proceeding before any agency, court or other
governmental authority relating to this Agreement or the Advances or the use of the proceeds
thereof, whether or not any Indemnified Person is a party thereto (all the foregoing, collectively,
the “Indemnified Liabilities”); provided, that Borrower shall have no obligation hereunder to any
Indemnified Person with respect to Indemnified Liabilities arising from the gross negligence or
willful misconduct of such Indemnified Person. The obligations in this Section shall survive the
Term. At the election of any Indemnified Person, Borrower shall defend such Indemnified Person
using legal counsel satisfactory to such Indemnified Person, at the sole cost and expense of
Borrower. All amounts owing under this Section shall be paid within 30 days after written demand.

8

 

11. Notices

All notices shall be in writing and personally delivered or sent by certified mail, postage
prepaid, return receipt requested, or by confirmed facsimile, at the respective addresses set forth
below:

	 	 	 	 	 
	 

	 	If to Borrower:
	 	If to Lender:
	 

	 	Concentric Medical, Inc.
	 	Lighthouse Capital Partners V, LP
	 

	 	1380 Shorebird Way
	 	500 Drake’s Landing Road
	 

	 	Mountain View, California 94043
	 	Greenbrae, California 94904
	 

	 	Attention: Vice President, Finance & Administration
	 	Attention: Contract Administrator
	 

	 	FAX: (650) 938-2700
	 	FAX: (415) 925-3387

12. General Provisions

12.1 Successors and Assigns. This Agreement shall bind and inure to the benefit of the parties’
respective successors and permitted assigns. Borrower may not assign any rights hereunder without
Lender’s prior written consent, which consent may be granted or withheld in Lender’s sole
discretion. Lender shall have the right without the consent of or notice to Borrower to sell,
transfer, negotiate, or grant participations in all or any part of any Loan Document.

12.2 Time of Essence. Time is of the essence for the performance of all Obligations.

12.3 Severability of Provisions. Each provision hereof shall be severable from every other
provision in determining its legal enforceability.

12.4 Entire Agreement. This Agreement and each of the other Loan Documents dated as of the date
hereof, taken together, constitute and contain the entire agreement between Borrower and Lender
with respect to their subject matter and supersede any and all prior agreements, negotiations,
correspondence, understandings and communications between the parties, whether written or oral.
This Agreement is the result of negotiations between and has been reviewed by the Borrower and
Lender as of the date hereof and their respective counsel; accordingly, this Agreement shall be
deemed to be the product of the parties hereto, and no ambiguity shall be construed in favor of or
against Borrower or Lender. This Agreement may only be modified with the written consent of Lender
and
Borrower. Any waiver or consent with respect to any provision of the Loan Documents shall be
effective only in the specific instance and for the specific purpose for which it was given. No
notice to or demand on a party in any one case shall entitle such party to any other or further
notice or demand in similar or other circumstances.

12.5 Reliance by Lender. All covenants, agreements, representations and warranties made herein by
Borrower shall, notwithstanding any investigation by Lender, be deemed to be material to and to
have been relied upon by Lender.

12.6 No Set-Offs by Borrower. All sums payable by Borrower pursuant to this Agreement or any of
the other Loan Documents shall be payable without notice or demand and shall be payable in United
States Dollars without set-off or reduction of any manner whatsoever.

12.7 Counterparts. This Agreement may be executed in any number of counterparts, each of which
shall be deemed to be an original, and all of which, when taken together, shall constitute one and
the same original instrument.

12.8 Survival. All covenants, representations and warranties made in this Agreement shall continue
in full force and effect so long as any Obligations remain outstanding. Upon the expiration of the
Term, this Agreement and all covenants, representations and warranties shall terminate and be of no
force and effect; provided, however, that the indemnity provisions of Section 10 shall survive for
a period of the longer of three years, or until the satisfaction in full of any outstanding
indemnity claim.

12.9 No Original Issue Discount. Borrower and Lender acknowledge and agree that the Warrant is
part of an investment unit within the meaning of Section 1273(c)(2) of the Internal Revenue Code,
which includes the Loan. Borrower and Lender further agree as between them, that the fair market
value of the Warrant is $100 and that, pursuant to Treas. Reg. § 1.1273-2(h), $100 of the issue
price of the investment unit will be allocable to the Warrant and the balance shall be allocable to
the Loans. Borrower and Lender agree to prepare their federal income tax returns in a manner
consistent with the foregoing and, pursuant to Treas. Reg. § 1.1273, the original issue discount on
the Loan shall be considered to be zero.

9

 

12.10 Relationship of Parties. The relationship between Borrower and Lender is, and at all times
shall remain, solely that of a borrower and lender. Lender is not a partner or joint venturer of
Borrower; nor shall Lender under any circumstances be deemed to be in a relationship of confidence
or trust or have a fiduciary relationship with Borrower or any of its affiliates, or to owe any
fiduciary duty to Borrower or any of its affiliates. Lender does not undertake or assume any
responsibility or duty to Borrower or any of its affiliates to select, review, inspect, supervise,
pass judgment upon or otherwise inform any of them of any matter in connection with its or their
property, the Loans, any Collateral or the operations of Borrower or any of its affiliates.
Borrower and each of its affiliates shall rely entirely on their own judgment with respect to such
matters, and any review, inspection, supervision, exercise of judgment or supply of information
undertaken or assumed by Lender in connection with such matters is solely for the protection of
Lender and neither Borrower nor any affiliate is entitled to rely thereon.

12.11 Confidentiality. Lender and Borrower agree that, except with the prior written permission of
the other party, the parties shall at all times hold in confidence and trust and not use or
disclose any confidential information provided to or learned by such party in connection with it’s
rights under the Loan Documents. Notwithstanding the foregoing, the parties may disclose any
confidential information of the other party provided to or learned by such party in connection with
such rights to the minimum extent necessary (i) in connection with the enforcement of this
Agreement or rights under this Agreement or the Loan Documents; (ii) as required by any court or
other governmental body, provided that such party provides the other party with prompt notice of
such court order or requirement to enable the party to seek a protective order or otherwise to
prevent or restrict such disclosure; (iii) to legal counsel of such party; (iv) to comply with
applicable law; or (v) with respect to financial information concerning the Borrower, to Lender’s
limited and general partners in accordance with Lender’s customary investment reporting practices.

12.12 Choice of Law and Venue; Jury Trial Waiver. This Agreement shall be governed by and
construed in accordance with, the internal laws of the State of California, without regard to
principles of conflicts of law. Each of Borrower and Lender hereby submits to the exclusive
jurisdiction of the State and Federal courts located in the City and County of San Francisco, State
of California. Borrower and Lender hereby waive their respective rights to a jury trial of any
claim or cause of action based upon or arising out of any of the Loan Documents or any of the
transactions contemplated therein, including contract claims, tort claims, breach of duty claims,
and all other common law or statutory claims. Each party further waives any right to consolidate
any action in which a jury trial has been waived with any other action in which a jury trial cannot
be or has not been waived.

In Witness Whereof, the parties hereto have executed this Agreement as of the date first
above written.

	 	 	 	 	 	 	 
	Concentric Medical, Inc.	 	Lighthouse Capital Partners V, L.P.
	 

	 	 	 	By:
	 	Lighthouse Management Partners V, L.L.C., its general partner
	 

	 	 	 	 	 	 
	 
	 	 	 	 	 	 
	By:

	 	/s/ Gary Curtis
	 	By:
	 	/s/ Thomas Conneely
	 

	 	 
	 	 	 	 
	 
	 	 	 	 	 	 
	Name:

	 	Gary Curtis
	 	Name:
	 	Thomas Conneely
	 

	 	 
	 	 	 	 
	 

	 	 	 	 	 	Duplicate Original
	Title:

	 	President, CEO
	 	Title:
	 	Vice President
	 

	 	 
	 	 	 	 

	 	 	 
	Exhibit A

	 	Collateral Description
	Exhibit B

	 	Form of Note
	Exhibit C

	 	Form of Preferred Stock Warrant
	Exhibit D

	 	Form of Notice of Borrowing
	Exhibit E

	 	Form of Incumbency Certificate
	Exhibit F

	 	Form of Officers Certificate
	Exhibit G

	 	ACH Authorization
	Exhibit H

	 	Form of Negative Pledge Agreement
	Exhibit I

	 	Control Agreement
	 
	 	 
	Schedule 1

	 	Disclosure Schedule

10

 

Exhibit A

Collateral

This FINANCING STATEMENT and SECURITY AGREEMENT covers all of Debtor’s interests in all of the
following types or items of property, wherever located and whether now owned or hereafter acquired,
and Debtor hereby grants Secured Party a security interest therein as collateral for the payment
and performance of all present and future indebtedness, liabilities, guarantees and obligations of
Debtor to Secured Party, howsoever arising. Debtor agrees that said security interest may be
enforced by Secured Party in accordance with the terms of all security and other agreements between
Secured Party and Debtor, the California Uniform Commercial Code, or both, and that this document
shall be fully effective as a security agreement, even if there is no other security or other
agreement between Secured Party or Debtor:

All assets of the Debtor; all personal property of Debtor;

All “accounts”, “general intangibles”, “chattel paper”, “contract rights”, “documents”,
“instruments”, “deposit accounts”, “inventory”, “farm products”, “fixtures” and “equipment”, as
such terms are defined in Division 9 of the California Uniform Commercial Code in effect on the
date hereof;

All general intangibles of every kind, including without limitation, federal, state and local tax
refunds and claims of all kinds; all rights as a licensee or any kind; all customer lists,
telephone numbers, and purchase orders, and all rights to purchase, lease sell, or otherwise
acquire or deal with real or personal property and all rights relating thereto;

All returned and repossessed goods and all rights as a seller of goods; all collateral securing any
of the foregoing; all deposit accounts, special and general, whether on deposit with Secured Party
or others;

All life and other insurance policies, claims in contract, tort or otherwise, and all judgments now
or hereafter arising therefrom;

All right, title and interest of Debtor, and all of Debtor’s rights, remedies, security and liens,
in, to and in respect of all accounts and other collateral, including, without limitation, rights
of stoppage in transit, replevin, repossession and reclamation and other rights and remedies of an
unpaid vendor, lienor or secured party, and all guarantees and other contracts of suretyship with
respect to any accounts and other collateral, and all deposits and other security for any accounts
and other collateral, and all credit and other insurance;

All notes, drafts, letters of credit, contract rights, and things in action; all drawings,
specifications, blueprints and catalogs; and all raw materials, work in process, materials used or
consumed in Debtor’s business, goods, finished goods, returned goods and all other goods and
inventory of whatsoever kind or nature, any and all wrapping, packaging, advertising and shipping
materials, and all documents relating thereto, and all labels and other devices, names and marks
affixed or to be affixed thereto for purposes of selling or identifying the same or the seller or
manufacturer thereof;

All inventory wherever located; all present and future claims against any supplier of any of the
foregoing, including claims for defective goods or overpayments to or undershipments by suppliers;
all proceeds arising from the lease or rental of any of the foregoing; INVENTORY RETURNED BY
DEBTOR TO ITS SUPPLIERS SHALL REMAIN SUBJECT TO SECURED PARTY’S SECURITY INTEREST; 

All equipment and fixtures, NONE OF WHICH THE DEBTOR IS AUTHORIZED TO SELL, LEASE OR OTHERWISE
DISPOSE OF WITHOUT THE WRITTEN CONSENT OF SECURED PARTY, including without limitation all
machinery, machine tools, motors, controls, parts, vehicles, workstations, tools, dies, jigs,
furniture, furnishings and fixtures; and all attachments, accessories, accessions and property now
or hereafter affixed to or used in connection with any of the foregoing, and all substitutions and
replacements for any of the foregoing; all warranty and other claims against any vendor or lessor
of any of the foregoing;

All investment property;

All books, records, ledger cards, computer data and programs and other property and general
intangibles at any time evidencing or relating to any or all of the foregoing; and

All cash and non-cash products and proceeds of any of the foregoing, in whatever form, including
proceeds in the form of inventory, equipment or any other form of personal property, including
proceeds of proceeds and proceeds of insurance, and all claims by Debtor against third parties for
loss or damage to, or destruction of, or otherwise relating to, any or all of the foregoing.

1

 

NOTICE — PURSUANT TO AN AGREEMENT BETWEEN DEBTOR AND SECURED PARTY, DEBTOR HAS AGREED NOT TO
FURTHER ENCUMBER THE COLLATERAL DESCRIBED HEREIN, THE FURTHER ENCUMBERING OF WHICH MAY CONSTITUTE
THE TORTIOUS INTERFERENCE WITH SECURED PARTY’S RIGHTS BY SUCH ENCUMBRANCER. IN THE EVENT THAT ANY
ENTITY IS GRANTED A SECURITY INTEREST IN DEBTOR’S ACCOUNTS, CHATTEL PAPER, GENERAL INTANGIBLES OR
OTHER ASSETS CONTRARY TO THE ABOVE, THE SECURED PARTY ASSERTS A CLAIM TO ANY PROCEEDS THEREOF
RECEIVED BY SUCH ENTITY.

Notwithstanding any of the foregoing, this Financing Statement and Security Agreement does not
cover any of Debtor’s interests in, and the Collateral shall not under any circumstance include,
and no security interest is granted in, (a) Debtor’s Intellectual Property, including, without
limitation, any and all property of the Debtor that is subject to, listed in or otherwise described
in the Negative Pledge Agreement dated November 22, 2004 between the Secured Party and the Debtor
and (b) any equipment subject to a “Permitted Lien,” as defined in Section 1.1 of the Loan and
Security Agreement dated November 22, 2004 between the Secured Party and the Debtor . “Intellectual
Property” means, collectively, all rights, priorities and privileges of the Debtor relating to
intellectual property, in any medium, of any kind or nature whatsoever, now or hereafter owned or
acquired or received by Debtor, or in which Debtor now holds or hereafter acquires or receives any
right or interest, whether arising under United States, multinational or foreign laws or otherwise,
and shall include, in any event, all copyrights, copyright licenses, patents, patent licenses,
trademarks, trademark licenses, trade secrets, internet domain names (including any right related
to the registration thereof), proprietary or confidential information, mask works, sources object
or other programming codes, inventions (whether or not patented or patentable), technical
information, procedures, designs, knowledge, know-how, software, data base, data, skill, expertise,
recipe, experience, process, models, drawings, materials or records. Notwithstanding the foregoing,
Intellectual Property as defined above does not include accounts, accounts receivable, royalties,
licensing fees, contract rights, proceeds, or other revenue obtained or owed from or on account of
the licensing or other exploitation of Intellectual Property, none of which are excluded, and all
of which are included as collateral in the security interest granted by Debtor to Secured Party.

	 	 	 	 	 	 	 	 	 
	“Debtor”	 	“Secured Party”	 	 
	 
	 	 	 	 	 	 	 	 
	Concentric Medical, Inc.,	 	Lighthouse Capital Partners V, L.P.	 	 
	a Delaware corporation	 	By:	 	Lighthouse Management Partners V, L.L.C.,	 	 
	 

	 	 	 	 	 	its general partner	 	 
	 
	 	 	 	 	 	 	 	 
	By:
	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	Name:

	 	 	 	By:	 	 	 	 
	 

	 	 

	 	 	 

	 	 
	 
	 	 	 	 	 	 	 	 
	Title:

	 	 	 	Name:	 	 	 	 
	 

	 	 
	 	 	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	 	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 	 	 

2

 

Exhibit B

[                    ]

Secured Promissory Note

This Secured Promissory Note (this “Note”) is made                     , 200___, by Concentric
Medical, Inc. (“Borrower”) in favor of Lighthouse Capital Partners V, L.P.
(collectively with its assigns, “Lender”), and its assigns (collectively, “Holder”) with reference
to the following:

For Value Received, Borrower promises to pay in lawful money of the United States, to the
order of Lender, at 500 Drake’s Landing Road, Greenbrae, California 94904, or such other place as
Lender may from time to time designate (“Lender’s Office”), the sum of $                     (the “Advance”)
evidenced hereby under that certain Loan and Security Agreement No. 4401 between Borrower and
Lender dated November 22, 2004 (the “Loan Agreement”), including interest on the unpaid balance of
the Advance at the Basic Rate accruing from the Funding Date, and all other amounts due or to
become due hereunder according to the terms hereof. Capitalized terms used and not otherwise
defined herein are defined in the Loan Agreement.

“Basic Rate” means a per annum variable rate of interest equal to the highest Prime Rate quoted in
the Wall Street Journal on the Funding Date, plus 1.75%, which rate shall vary concurrently
with any change in the Prime Rate. On and after a particular Advance’s Funding Date, there will be
no further adjustments to the Basic Rate for the Advance evidenced by this Note.

“Final Payment” means 8% of the original principal amount of the Note.

“Loan Commencement Date” for this Note means October 1, 2005.

“Maturity Date” means the last day of the Repayment Period, or if earlier, the date of prepayment
under the Note.

“Payment Factor” for this Note means [3.0484%], subject to changes in Basic Rate.

“Repayment Period” means the period beginning on the Loan Commencement Date and continuing for 36
calendar months.

1. Repayment. Borrower shall repay the principal and interest thereupon will be paid as follows:

     a. Scheduled Payments. From and after the Loan Commencement Date, Borrower shall make
amortizing payments of principal and interest in advance (collectively, “Scheduled Payments”) on
the first day of each month during the Repayment Period (each a “Payment Date”), in an amount equal
to the Payment Factor multiplied by the original principal amount of the Advance. In
addition, all unpaid principal and accrued interest, together with all Lenders Expenses associated
with the Advance and this Note shall be due and payable in full on the Maturity Date.

     b. Interim Payments. In addition to the Scheduled Payments, Borrower shall pay to Lender,
monthly in advance, an amount (the “Interim Payment”) equal to accrued interest on the aggregate
principal amount of this Note calculated at the Basic Rate from the Funding Date (and thereafter
recalculated on the first business day of each calendar month during which an Interim Payment is
due), until the Loan Commencement Date with respect to this Note.

     c. Final Payment. On the Maturity Date, Borrower shall pay, in addition to all unpaid
principal and interest due hereunder, the Final Payment.

2. Interest. Interest not paid when due will, to the maximum extent permitted under applicable
law, become part of principal, at Lender’s option, and thereafter bear like interest as principal.
All Obligations not paid when due shall bear interest at the Default Rate unless waived in writing
by Lender. All amounts paid hereunder including principal, interest or fees and expenses will be
applied to the payment of the Obligations in Lender’s discretion and as provided in the Loan
Agreement.

3. Voluntary Prepayment. Borrower may prepay the Note if and only if it Borrower pays to Lender
(i) the outstanding principal amount of this Note and any unpaid accrued interest (ii) the Final
Payment, and (iii) all other sums, if any, that shall have become due and payable hereunder with
respect to this Note,.

4. Collateral. This Note is secured by the Collateral.

1

 

5. Waivers. Borrower, and all guarantors and endorsers of this Note, regardless of the time, order
or place of signing, hereby waive notice, demand, presentment, protest, and notices of every kind,
presentment for the purpose of accelerating maturity, diligence in collection, and, to the fullest
extent permitted by law, all rights to plead any statute of limitations as a defense to any action
on this Note.

6. Choice of Law; Venue. This Note shall be governed by, and construed in accordance with the
internal laws of the State of California, without regard to principles of conflicts of law. Each
of Borrower and Lender hereby submits to the exclusive jurisdiction of the State and Federal courts
located in the City and County of San Francisco, State of California. Borrower and Lender Each
hereby waive their respective rights to a jury trial of any claim or cause of action based upon or
arising out of this Note. Each party further waives any right to consolidate any action in which a
jury trial has been waived with any other action in which a jury trial cannot be or has not been
waived.

7. Miscellaneous. This Note may be modified only by a writing signed by Borrower and
Lender. Each provision hereof is severable from every other provision hereof and of the Loan
Agreement when determining its legal enforceability. Sections and subsections are titled for
convenience, and not for construction. “Hereof,” “herein,” “hereunder,” and similar words refer to
this Note in its entirety. “Or” is not necessarily exclusive. “Including” is not limiting. The
terms and conditions hereof inure to the benefit of and are binding upon the parties’ respective
permitted successors and assigns. This Note is subject to all the terms and conditions of the Loan
Agreement.

In Witness Whereof, Borrower has caused this Note to be executed by a duly authorized
officer as of the day and year first above written.

	 	 	 	 	 	 
	 	 	Concentric Medical, Inc.
	 
	 	 	 	 	 
	 

	 	By:	 	 	 
	 

	 	 	 	 	 
	 
	 	 	 	 	 
	 

	 	Name:	 	 	 
	 

	 	 	 	 	 
	 
	 	 	 	 	 
	 

	 	Title:	 	 	 
	 

	 	 	 	 	 

2

 

Exhibit c

Warrants

[Intentionally Omitted]

1

 

Exhibit d

Notice of Borrowing

                    , ____

Lighthouse Capital Partners V, L.P.

500 Drake’s Landing Road

Greenbrae, CA 94904-3011

Ladies and Gentlemen:

     Reference is made to the Loan and Security Agreement No. 4401 dated as of November 22, 2004
(as it has been and may be amended from time to time, the “Loan Agreement,” initially capitalized
terms used herein as defined therein), between Lighthouse Capital Partners V, L.P. and
Concentric Medical, Inc. (the “Company”)

     The undersigned is the President and CEO of the Company, and hereby irrevocably requests an
Advance under the Loan Agreement, and in that connection certifies as follows:

     1. The amount of the proposed Advance is $                     . The business day of the proposed
Advance is                     .

     2. The Loan Commencement Date for this Advance shall be October 1, 2005.

     3. As of this date, no Event of Default, or event which with notice or the passage of time
would constitute an Event of Default, has occurred and is continuing, or will result from the
making of the proposed Advance, and the representations and warranties of the Company contained in
Section 5 of the Loan Agreement, as modified by the Disclosure Schedule and any supplement attached
hereto, are true and correct in all material respects.

     4. No event that could reasonably be expected to have a material adverse effect on the ability
of Borrower to fulfill its obligations under the Loan Agreement has occurred since the date of the
most recent financial statements, submitted to you by the Company.

     The Company agrees to notify you promptly before the funding of the Advance if any of the
matters to which I have certified above shall not be true and correct on the Borrowing Date.

	 	 	 	 	 	 
	 	 	Very truly yours,
	 
	 	 	 	 	 
	 	 	Concentric Medical, Inc.	 
	 
	 	 	 	 	 
	 

	 	By:	 	 	 
	 

	 	 	 	 	 
	 
	 	 	 	 	 
	 

	 	Name:	 	 	 
	 

	 	 	 	 	 
	 
	 	 	 	 	 
	 

	 	Title:	 	 	 
	 

	 	 	 	 	 

1

 

Exhibit e

Incumbency Certificate

     The undersigned, Edward Y. Kim, hereby certifies that:

1. He/She is the duly elected and acting Secretary of Concentric Medical, Inc., a Delaware
corporation (the “Company”).

2. That on the date hereof, each person listed below holds the office in the Company indicated
opposite his or her name and that the signature appearing thereon is the genuine signature of each
such person:

	 	 	 	 	 
	NAME	 	OFFICE	 	SIGNATURE
	Gary Curtis

	 	President and Chief	 	 
	 

	 	 	 	 
	 

	 	Executive Officer	 	 
	 
	 	 	 	 
	Jill Papp

	 	Vice President, Finance	 	 
	 

	 	 	 	 
	 

	 	and Administration	 	 

3. Attached hereto as Exhibit A is a true and correct copy of the Certificate of Incorporation of
the Company, as amended, as in effect as of the date hereof.

4. Attached hereto as Exhibit B is a true and correct copy of the Bylaws of the Company, as
amended, as in effect as of the date hereof.

5. Attached hereto as Exhibit C is a copy of the resolutions of the Board of Directors of the
Company authorizing and approving the Company’s execution, delivery and performance of a loan
facility with Lighthouse Capital Partners V, L.P.

     IN WITNESS WHEREOF, the undersigned has executed this Incumbency Certificate on November 22,
2004.

	 	 	 	 	 	 
	 	 	Concentric Medical, Inc.
	 
	 	 	 	 	 
	 

	 	By:	 	 	 
	 

	 	 	 	 	 
	 
	 	 	 	 	 
	 

	 	Name:
	 	Edward Y. Kim	 
	 
	 	 	 	 	 
	 

	 	Title:
	 	Secretary	 

     I, the Vice President, Finance and Administration of the Company, do hereby certify that
Edward Y. Kim is the duly qualified, elected and acting Secretary of the Company and that the above
signature is his or her genuine signature.

     IN WITNESS WHEREOF, the undersigned has executed and delivered this Incumbency Certificate on
November 22, 2004.

	 	 	 	 	 	 
	 	 	Concentric Medical, Inc.
	 
	 	 	 	 	 
	 

	 	By:	 	 	 
	 

	 	 	 	 	 
	 
	 	 	 	 	 
	 

	 	Name:
	 	Jill Papp	 
	 
	 	 	 	 	 
	 

	 	Title:
	 	Vice President, Finance and Administration	 

1

 

Exhibit f

Officer’s Certificate

     The undersigned, to induce Lighthouse Capital Partners V, L.P. (“Lender”), to extend
or continue financial accommodations to Concentric Medical, Inc., a Delaware corporation
(the “Borrower”) pursuant to the terms of that certain Loan and Security Agreement dated November
22, 2004 (the “Loan Agreement”), hereby certifies that on the date hereof:

     1. I am the duly elected and acting                      of Borrower.

     2. I am a Responsible Officer as that term is defined in the Loan Agreement.

     3. The information submitted herewith is in fact what it purports to be.

     4. The information delivered herewith is true, correct and complete

     5. Borrower is currently able to meet its obligations as they come due.

     6. I understand that Lender is relying upon the truthfulness, accuracy and
completeness hereof in connection with the Loan Agreement.

     7. Borrower will advise Lender if it comes to its attention that, as of the date
hereof, the information submitted herewith was not in fact true, correct and complete.

     IN WITNESS WHEREOF, the undersigned has executed this Officer’s Certificate on                     .

	 	 	 	 	 	 
	 	 	Concentric Medical, Inc.
	 
	 	 	 	 	 
	 

	 	By:	 	 	 
	 

	 	 	 	 	 
	 
	 	 	 	 	 
	 

	 	Name:	 	 	 
	 

	 	 	 	 	 
	 
	 	 	 	 	 
	 

	 	Title:	 	 	 
	 

	 	 	 	 	 

1

 

Exhibit g

Authorization for Automatic Payment

The undersigned Concentric Medical, Inc. (“Borrower”) authorizes Lighthouse Capital
Partners V, L.P. and any and all affiliated funds (collectively, “Lender”) and the bank /
financial institution (“Bank”) named below to initiate variable debit and/or credit entries to
Borrower’s deposit, checking or savings accounts as designated below and to cause funds transfers
to an account of Lender as payment of any and all amounts due under the Loan and Security Agreement
between Borrower and Lender dated November 22, 2004 (the “Loan Agreement”).

1. Lender is hereby authorized to initiate variable debit and/or credit transactions and resulting
funds transfers in Borrower’s designated accounts with respect to amounts calculated by Lender to
be due and owing to Lender by Borrower periodically under the Loan Agreement. Borrower consents to
all such debit and/or credit transactions and resulting funds transfers and hereby authorizes
Lender to take all such actions as may be required by Bank with respect to such transactions.
Borrower acknowledges and agrees that such credit and/or debit entries may be made in amounts due
under the Loan Agreement in order to cause timely payments as required by the terms of the Loan
Agreement.

2. Borrower hereby authorizes Lender to release to Bank all information concerning Borrower that
may be necessary or desirable for Bank to investigate or recover any erroneous funds transfers that
may occur.

3. Borrower acknowledges and agrees that all such debit and/or credit transactions and funds
transfers are intended to be made through an Automated Clearing House system and in compliance with
the NACHA Rules and in compliance with Bank’s security procedures.

4. Borrower represents and warrants that the account information set forth below is accurate and
complete and that each of the account(s) set forth below is a business account maintained in
Borrower’s name and for Borrower’s account.

This Consent shall be effective as of November 22, 2004 and shall remain in effect until the Loan
Agreement has been terminated. Any cancellation by Borrower of this consent shall (i) be made in
writing and (ii) delivered to Bank and Lender in such time as to afford Bank and Lender a
reasonable opportunity to act on said cancellation.

	 	 	 	 	 
	 

	 	          Silicon Valley Bank	 	 
	 

	 	 

(Name of Borrower’s Bank)
	 	 

	 	 	 	 	 	 	 	 	 	 	 
	 

	 	     3003 Tasman Dr.
	 	Santa Clara
	 	CA
	 	95054	 	 
	 	 	 	 	 
	 

	 	(Address of Bank)
	 	(City)
	 	(State)
	 	(Zip Code)	 	 

	 	 	 	 	 	 	 
	 

	 	Bank Routing Number
	 	      #121140399
 

     (between these symbols ” /:” “:/” on bottom left of check)
	 	 

	 	 	 	 	 
	 

	 	Account Number:
	 	     #3300407054 (money market)       (checking / deposit / savings)   (circle one)
	 
	 	 	 	 
	 	 	Copy of a voided check is attached to this form

	 	 	 	 	 	 	 
	Borrower Name:	 	Concentric Medical, Inc.	 	 
	Borrower Address:	 	1380 Shorebird Way	 	 
	 	 	Mountain View, CA 94043	 	 
	 
	 	 	 	 	 	 
	Authorized by:
	 	 	 	 	 	 
	 	 	 	 	 
	 

	 	Its:	 	 	 	 
	 
	Date authorized:

	 	 	 
	 	 	 	 	 

Internal ACH Authorizations from Lender:

	 	 	 	 	 	 	 	 	 	 
	 

	 	Approved by:
	 	 	 	Date: 	 	 	 
	 

	 	 	 	 
	 	 	 	 	 

1

 

Exhibit h

Negative Pledge Agreement

          This Negative Pledge Agreement
is made as of November 22, 2004, by and between
Concentric Medical, Inc. (“Borrower”) and Lighthouse Capital Partners V, L.P.
(“Lender”).

In consideration of the Loan and Security Agreement between the parties of proximate date herewith
(the “Loan Agreement”), Borrower agrees as follows:

1. Except as otherwise permitted in the Loan Agreement, Borrower shall not during the Term (as
defined in the Loan Agreement) sell, transfer, assign, mortgage, pledge, lease, grant a security
interest in, or encumber any of Borrower’s intellectual property, including, without limitation,
the following:

(a) Any and all copyright rights, copyright applications, copyright registration and like
protection in each work or authorship and derivative work thereof, whether published or unpublished
and whether or not the same also constitutes a trade secret, now or hereafter existing, created,
acquired or held (collectively, the “Copyrights”);

(b) Any and all trade secrets, and any and all intellectual property rights in computer software
and computer software products now or hereafter existing, created, acquired or held;

(c) Any and all design rights which may be available to Borrower now or hereafter existing,
created, acquired or held;

(d) All patents, patent applications and like protections, including, without limitation,
improvements, divisions, continuations, renewals, reissues, extensions and continuations-in-part of
the same, including, without limitation, the patents and patent applications (collectively, the
“Patents”);

(e) Any trademark and servicemark rights, whether registered or not, applications to register and
registrations of the same and like protections, and the entire goodwill of the business of Borrower
connected with and symbolized by such trademarks (collectively, the “Trademarks”);

(f) Any and all claims for damages by way of past, present and future infringements of any of the
rights included above, with the right, but not the obligation, to sue for an collect such damages
for said use or infringement of the intellectual property rights identified above;

(g) Any and all licenses or other rights to use any of the Copyrights, Patents or Trademarks and
all license fees and royalties arising from such use to the extent permitted by such license or
rights

(h) Any and all amendments, extensions, renewals and extensions of any of the Copyrights, Patents
or Trademarks; and

(i) Any and all proceeds and products of the foregoing, including, without limitation, all payments
under insurance or any indemnity or warranty payable in respect of any of the foregoing.

2. Notwithstanding the foregoing, nothing herein shall be deemed to prevent or prohibit Borrower
from licensing its intellectual property to third parties in the ordinary course of business or as
approved by Borrower’s board of directors, provided that such license does not amount to a de facto
acquisition of substantially all of Borrower’s intellectual property.

3. It shall be an Event of Default under the Loan Agreement if there is a breach of any term of
this Negative Pledge Agreement. Borrower agrees to properly execute all documents reasonably
required by Lender in order to fulfill the intent and purposes hereof.

	 	 	 	 	 	 	 	 	 	 	 
	Concentric Medical, Inc.	 	 	 	Lighthouse Capital Partners V, L.P.	 	 
	 
	 	 	 	 	 	 	 	 	 	 
	By:	 	 	 	 	 	By: Lighthouse Management Partners V, L.L.C.,	 	 
	 

	 

	 	 	 	 its general partner	 	 
	Name:
	 	 	 	 	 	 	 	 	 	 
	 

	 

	 	 	 	By:	 	 	 	 
	 
	 	 	 	 	 	 	 

	 	 
	Title:
	 	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	 	 	 	 
	 

	 	 	 	 	 	Name:	 	 	 	 
	 

	 	 	 	 	 	 	 

	 	 
	 

	 	 	 	 	 	Title:	 	 	 	 
	 

	 	 	 	 	 	 	 

	 	 

1

 

Exhibit I

Control Agreement

[Intentionally Omitted]

1

 

Schedule 1

Disclosure Schedule

Deposit and Securities Accounts

	 	 	 	 	 	 	 	 	 
	 	 	 	 	 	 	Contact Information for
	 	 	Account Information:	 	Account:
	 

	 	Company Name:
	 	Silicon Valley Bank	 	Contact Name:
	 	Lily Pang
	Account

	 	Address:
	 	3003 Tasman Drive	 	Phone:
	 	(650) 320-1113  
	Number

	 	City, State, Zip:
	 	Santa Clara, CA 95054	 	Fax:
	 	(650) 320-0018 
	1

	 	Phone:
	 	(650) 320-1113 	 	E-mail:
	 	lpang@svbank.com
	 

	 	Fax:
	 	(650) 320-0018 
	 	 	 	 
	 

	 	Type of Account:
	 	Money Market account
	 	 	 	 
	 

	 	Account number:
	 	3300407054 
	 	 	 	 
	 

	 	Approximate Dollar Amount:
	 	$3,285,121 
	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	Company Name:
	 	Silicon Valley Bank	 	Contact Name:
	 	Lily Pang
	Account

	 	Address:
	 	3003 Tasman Drive	 	Phone:
	 	(650) 320-1113 
	Number

	 	City, State, Zip:
	 	Santa Clara, CA
95054 	 	Fax:
	 	(650) 320-0018 
	2

	 	Phone:
	 	(650) 320-1113 	 	E-mail:
	 	lpang@svbank.com
	 

	 	Fax:
	 	(650) 320-0018 
	 	 	 	 
	 

	 	Type of Account:
	 	Checking account
	 	 	 	 
	 

	 	Account number:
	 	3300421390 
	 	 	 	 
	 

	 	Approximate Dollar Amount:
	 	$278,252 
	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	Company Name:
	 	Merrill Lynch	 	Contact Name:
	 	Thomas Vickers
	Account

	 	Address:
	 	600 California St.
8th Floor	 	Phone:
	 	(415) 576-8622 
	Number

	 	 	 	 	 	Fax:
	 	(415) 576-8626 
	3

	 	City, State, Zip:
	 	San Francisco, CA 94108	 	E-mail:
	 	Thomas_Vickers@ml.com
	 

	 	Phone:
	 	(415) 576-8622 	 	 	 	 
	 

	 	Fax:
	 	(415) 576-8626 
	 	 	 	 
	 

	 	Type of Account:
	 	securities
	 	 	 	 
	 

	 	Account number:
	 	#6CA-07210 
	 	 	 	 
	 

	 	Approximate Dollar Amount:
	 	$10,380,000 
	 	 	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	Company Name:	 	 	 	Contact Name:	 	 
	Account

	 	Address:	 	 	 	Phone:	 	 
	Number

	 	City, State, Zip:	 	 	 	Fax:	 	 
	4

	 	Phone:	 	 	 	E-mail:	 	 
	 

	 	Fax:
	 	 	 	 	 	 
	 

	 	Type of Account:
	 	 	 	 	 	 
	 

	 	Account number:
	 	 	 	 	 	 
	 

	 	Approximate Dollar Amount:
	 	 	 	 	 	 

Permitted Liens

	 	 	 
	Existing Liens 

	 	Equipment lease with Xerox Corporation dated as of April 23, 2004

Subsidiaries

1

 

None

Litigation and Administrative Proceedings

None

Business Premises

	 	 	 	 	 	 	 	 	 
	 	 	Each Location Address where Lighthouse	 	Landlord/Property Management
	 	 	Capital Partners has financed assets:	 	Information:
	Current

	 	Contact Name:
	 	 	 	Contact Name:
	 	Lisa Weiblen, Assistant
	Headquarters

	 	Address:
	 	1380 Shorebird Way
	 	 	 	Property Manager
	(Location 1)

	 	 	 	 	 	Company Name:
	 	DivcoWest Property
	 

	 	City, State, Zip:
	 	Mountain View, CA 94043
	 	Services, LLC	 	 
	 

	 	Phone:
	 	(650) 938-2100 
	 	Address:
	 	100 Park Center Plaza, Suite 425
	 

	 	Fax:	 	(650) 938-2700	 	City, State, Zip:
	 	San Jose, CA 95113 
	 

	 	 	 	 	 	Phone:
	 	(408) 977-0277 
	 

	 	 	 	 	 	Fax:
	 	(408) 977-0523  
	 
	 	 	 	 	 	 	 	 
	Location

	 	Contact Name:
	 	 	 	Contact Name:	 	 
	2

	 	Company Name:
	 	 	 	Company Name:	 	 
	 

	 	Address:
	 	 	 	Address:	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	City, State, Zip:
	 	 	 	City, State, Zip:	 	 
	 

	 	Phone:
	 	 	 	Phone:	 	 
	 

	 	Fax:
	 	 	 	Fax:	 	 
	 
	 	 	 	 	 	 	 	 
	Location

	 	Contact Name:
	 	 	 	Contact Name:	 	 
	3

	 	Company Name:
	 	 	 	Company Name:	 	 
	 

	 	Address:
	 	 	 	Address:	 	 
	 
	 	 	 	 	 	 	 	 
	 

	 	City, State, Zip:
	 	 	 	City, State, Zip:	 	 
	 

	 	Phone:
	 	 	 	Phone:	 	 
	 

	 	Fax:
	 	 	 	Fax:	 	 

2

 

$1,000,000.00

Secured Promissory Note

This Secured Promissory Note (this “Note”) is made March 30, 2005, by Concentric
Medical, Inc. (“Borrower”) in favor of Lighthouse Capital Partners V, L.P.
(collectively with its assigns, “Lender”), and its assigns (collectively, “Holder”) with reference
to the following:

For Value Received, Borrower promises to pay in lawful money of the United States, to the
order of Lender, at 500 Drake’s Landing Road, Greenbrae, California 94904, or such other place as
Lender may from time to time designate (“Lender’s Office”), the sum of $1,000,000.00 (the
“Advance”) evidenced hereby under that certain Loan and Security Agreement No. 4401 between
Borrower and Lender dated November 22, 2004 (the “Loan Agreement”), including interest on the
unpaid balance of the Advance at the Basic Rate accruing from the Funding Date, and all other
amounts due or to become due hereunder according to the terms hereof. Capitalized terms used and
not otherwise defined herein are defined in the Loan Agreement.

“Basic Rate” means a per annum variable rate of interest equal to the highest Prime Rate quoted in
the Wall Street Journal on the Funding Date, plus 1.75%, which rate shall vary concurrently
with any change in the Prime Rate. On and after a particular Advance’s Funding Date, there will be
no further adjustments to the Basic Rate for the Advance evidenced by this Note.

“Final Payment” means 8% of the original principal amount of the Note.

“Loan Commencement Date” for this Note means October 1, 2005.

“Maturity Date” means the last day of the Repayment Period, or if earlier, the date of prepayment
under the Note.

“Payment Factor” for this Note means [3.0484%], subject to changes in Basic Rate.

“Repayment Period” means the period beginning on the Loan Commencement Date and continuing for 36
calendar months.

1. Repayment. Borrower shall repay the principal and interest thereupon will be paid as follows:

     a. Scheduled Payments. From and after the Loan Commencement Date, Borrower shall make
amortizing payments of principal and interest in advance (collectively, “Scheduled Payments”) on
the first day of each month during the Repayment Period (each a “Payment Date”), in an amount equal
to the Payment Factor multiplied by the original principal amount of the Advance. In
addition, all unpaid principal and accrued interest, together with all Lenders Expenses associated
with the Advance and this Note shall be due and payable in full on the Maturity Date.

     b. Interim Payments. In addition to the Scheduled Payments, Borrower shall pay to Lender,
monthly in advance, an amount (the “Interim Payment”) equal to accrued interest on the aggregate
principal amount of this Note calculated at the Basic Rate from the Funding Date (and thereafter
recalculated on the first business day of each calendar month during which an Interim Payment is
due), until the Loan Commencement Date with respect to this Note.

     c. Final Payment. On the Maturity Date, Borrower shall pay, in addition to all unpaid
principal and interest due hereunder, the Final Payment.

2. Interest. Interest not paid when due will, to the maximum extent permitted under applicable
law, become part of principal, at Lender’s option, and thereafter bear like interest as principal.
All Obligations not paid when due shall bear interest at the Default Rate unless waived in writing
by Lender. All amounts paid hereunder including principal, interest or fees and expenses will be
applied to the payment of the Obligations in Lender’s discretion and as provided in the Loan
Agreement.

3. Voluntary Prepayment. Borrower may prepay the Note if and only if it Borrower pays to Lender
(i) the outstanding principal amount of this Note and any unpaid accrued interest (ii) the Final
Payment, and (iii) all other sums, if any, that shall have become due and payable hereunder with
respect to this Note,.

4. Collateral. This Note is secured by the Collateral.

5. Waivers. Borrower, and all guarantors and endorsers of this Note, regardless of the time, order
or place of signing, hereby waive notice, demand, presentment, protest, and notices of every kind,
presentment for the purpose of accelerating maturity, diligence

 

 

in collection, and, to the fullest extent permitted by law, all rights to plead any statute of
limitations as a defense to any action on this Note.

6. Choice of Law; Venue. This Note shall be governed by, and construed in accordance with the
internal laws of the State of California, without regard to principles of conflicts of law. Each
of Borrower and Lender hereby submits to the exclusive jurisdiction of the State and Federal courts
located in the City and County of San Francisco, State of California. Borrower and Lender Each
hereby waive their respective rights to a jury trial of any claim or cause of action based upon or
arising out of this Note. Each party further waives any right to consolidate any action in which a
jury trial has been waived with any other action in which a jury trial cannot be or has not been
waived.

7. Miscellaneous. This Note may be modified only by a writing signed by Borrower and
Lender. Each provision hereof is severable from every other provision hereof and of the Loan
Agreement when determining its legal enforceability. Sections and subsections are titled for
convenience, and not for construction. “Hereof,” “herein,” “hereunder,” and similar words refer to
this Note in its entirety. “Or” is not necessarily exclusive. “Including” is not limiting. The
terms and conditions hereof inure to the benefit of and are binding upon the parties’ respective
permitted successors and assigns. This Note is subject to all the terms and conditions of the Loan
Agreement.

In Witness Whereof, Borrower has caused this Note to be executed by a duly authorized
officer as of the day and year first above written.

	 	 	 	 	 
	 	Concentric Medical, Inc.

 	 
	 	By:  	/s/ Gary Curtis
 	 
	 	Name:  	Gary Curtis 	 	 
	 	Title:  	President and CEO

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00130-of-00352.parquet"}]]